<DOC>
	<DOCNO>NCT00931359</DOCNO>
	<brief_summary>This prospective , multi-center , parallel , randomized , blind study . The study two group , one study group subject receive treatment axillary hyperhidrosis ( excessive underarm sweating ) DTS-G2 System axilla ( `` treatment group '' ) . The study group receive sham treatment axilla subject procedure perform energy device apply ( `` sham group '' ) . Subjects randomized 2:1 ratio ( treatment group : sham group ) . Subjects enrol study blind regard study group . The study hypothesis subject receive treatment reduction underarm sweating compare sham group , measure quality life questionnaire . All subject undergo follow assessment 14 day , 30 day , 3 month 6 month post final treatment session . Subjects randomized treatment group also follow-up visit 9 month 12 month post final treatment session .</brief_summary>
	<brief_title>Efficacy Safety DTS-G2 System Patients With Axillary Hyperhidrosis</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<criteria>baseline gravimetric measurement spontaneous rest sweat production least 50 mg/5 min room temperature axilla poor qualityoflife rating Hyperhidrosis Disease Severity Scale primary focal axillary hyperhidrosis evidence least two standard criterion female subject childbearing potential must pregnant lactating must agree become pregnant course study include followup period female subject 40 must mammogram last 2 year subject must willing comply study visit requirement subject secondary hyperhidrosis ( e.g. , endocrinopathy , medication ) subject active infection subject pregnant lactating subject prior surgery axillary hyperhidrosis subject axillary injection botulinum toxin A last year subject use prescription antiperspirant last 14 day plan use study period subject use oral anticholinergic last 4 week subject prisoner incarceration subject participate another clinical trial ( last 30 day ) subject history cancer ( exception ) subject pacemaker electronic implant subject require supplemental oxygen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>axillary</keyword>
	<keyword>hyperhidrosis</keyword>
	<keyword>primary focal</keyword>
</DOC>